Table 4.
Comparison of the patients with and without falls
Without falls | With falls | ||||
---|---|---|---|---|---|
Mean ± SD | Range | Mean ± SD | Range | z; p | |
Age (years) | 63.81±10.87 | 27–85 | 69.72±8.71 | 50–84 | 3.008; 0.003 |
Duration of disease (years) | 5.69±4.59 | 1–30 | 10.00±8.26 | 1–37 | 3.178; 0.001 |
UPDRS motor score | 16.52±8.56 | 1–36 | 21.72±7.94 | 2–41 | 3.170; 0.002 |
HYS | 1.91±0.733 | 1–3 | 2.767±0.812 | 1–4 | 4.987; <0.001 |
Levodopa equivalent dose (mg) | 641.12±429.17 | 0–2550 | 750.07±574.62 | 0–2319 | 0.660; 0.509 |
FOG Questionnaire score | 6.16±6.89 | 0–23 | 14.12±7.26 | 0–24 | 5.087; <0.001 |
VAS score | 3.57±3.82 | 0–10 | 4.86±3.58 | 0–10 | 1.670; 0.095 |
SD, standart deviation; UPDRS, unified Parkinson’s disease rating scale; HYS, Hoehn and Yahr scale; FOG, freezing of gait; VAS, visual analog scale.